Melissa Epperly
Director/Board Member chez NAUTILUS BIOTECHNOLOGY, INC.
Fortune : 7 M $ au 31/03/2024
Profil
Melissa B.
Epperly is currently an Independent Director at Roivant Sciences Ltd., a Director at Nautilus Subsidiary, Inc., an Independent Director at Nautilus Biotechnology, Inc., and a Trustee at The Andalusia Foundation.
Previously, she held positions as a Director at Anchorage Capital Group LLC from 2012 to 2015, an Independent Director at Kinnate Biopharma, Inc. from 2020 to 2024, a Research Analyst at Goldman Sachs International, an Analyst at Goldman Sachs & Co. LLC from 2010 to 2012, the Chief Financial Officer at Akamis Bio Ltd.
from 2018 to 2019, the Chief Financial Officer at R-Pharm US LLC from 2015 to 2018, and the Treasurer, Chief Financial & Accounting Officer at Zentalis Pharmaceuticals, Inc. from 2019 to 2024.
Ms. Epperly obtained an undergraduate degree from the University of Virginia and an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/02/2024 | 451 449 ( 0,64% ) | 7 M $ | 31/03/2024 | |
ROIVANT SCIENCES LTD.
0,00% | 19/01/2024 | 21 538 ( 0,00% ) | 227 011 $ | 31/03/2024 |
KINNATE BIOPHARMA, INC.
-.--% | 03/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Melissa Epperly
| Sociétés | Poste | Début |
|---|---|---|
| NAUTILUS BIOTECHNOLOGY, INC. | Director/Board Member | 09/06/2021 |
| ROIVANT SCIENCES LTD. | Director/Board Member | 29/06/2022 |
Nautilus Subsidiary, Inc.
 Nautilus Subsidiary, Inc. Information Technology ServicesTechnology Services Nautilus Biotechnology, Inc. operates as a biopharmaceutical company. The company was founded by Sujal Patel and Parag Mallick in 2016 and is headquartered in San Carlos, CA. | Director/Board Member | - |
| The Andalusia Foundation | Director/Board Member | - |
Anciens postes connus de Melissa Epperly
| Sociétés | Poste | Fin |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Director of Finance/CFO | 05/04/2024 |
| KINNATE BIOPHARMA INC. | Director/Board Member | 03/04/2024 |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Director of Finance/CFO | 01/08/2019 |
R-Pharm US LLC
 R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ. | Director of Finance/CFO | 01/06/2018 |
Anchorage Capital Group LLC
 Anchorage Capital Group LLC Investment ManagersFinance Anchorage Capital Group LLC is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Kevin Ulrich in 2003 as Anchorage Advisors LLC. They are a subsidiary of Anchorage Advisors Management LLC. Anchorage Capital Group provides investment advisory services to private investment funds and structured credit vehicles. | Director/Board Member | 01/09/2015 |
Formation de Melissa Epperly
| University of Virginia | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ROIVANT SCIENCES LTD. | Health Technology |
| ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
| NAUTILUS BIOTECHNOLOGY, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Goldman Sachs International
 Goldman Sachs International Financial ConglomeratesFinance Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals. | Finance |
Anchorage Capital Group LLC
Anchorage Capital Group LLC Investment ManagersFinance Anchorage Capital Group LLC is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Kevin Ulrich in 2003 as Anchorage Advisors LLC. They are a subsidiary of Anchorage Advisors Management LLC. Anchorage Capital Group provides investment advisory services to private investment funds and structured credit vehicles. | Finance |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ. | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
Nautilus Subsidiary, Inc.
Nautilus Subsidiary, Inc. Information Technology ServicesTechnology Services Nautilus Biotechnology, Inc. operates as a biopharmaceutical company. The company was founded by Sujal Patel and Parag Mallick in 2016 and is headquartered in San Carlos, CA. | Technology Services |
| The Andalusia Foundation |
